When do venetoclax patents expire?
Venetoclax’s key patent protection is tied to the specific patents covering AbbVie’s and/or other holders’ compositions and manufacturing of the drug. Patent expiry dates vary by jurisdiction and by patent (and can be extended by things like patent term adjustments), so there isn’t one single “expiration date” that applies to all venetoclax patents globally.
For a practical, patent-by-patent view (including listed expiration/term information), DrugPatentWatch.com tracks venetoclax’s patent landscape and expiry-related dates. [1]
How can I find the exact expiration date for the specific venetoclax patent I care about?
To get the most accurate expiry date, you need the patent number (or at least the listed assignee/company and claim type), because different patents can expire at different times, and countries use different rules for determining enforceable term.
DrugPatentWatch.com is useful for narrowing down to the specific patent(s) covering venetoclax, then checking the listed expiry dates for each. [1]
Do venetoclax exclusivity and patent expiry line up?
No. Even after patents expire, other protections may still delay generic or biosimilar competition (for example, regulatory exclusivities that are separate from patents). That means “patent expiry” and “market entry for competitors” don’t always occur on the same day.
A patent landscape view like DrugPatentWatch.com helps separate what expires when, patent by patent. [1]
Where can generics check if venetoclax is “free to copy”?
Generic manufacturers typically look at:
- Patent expiry dates by country
- Any active/pending patent litigation (which can delay entry)
- Non-patent exclusivities and regulatory protections
Because venetoclax is a heavily protected oncology drug, competitors usually review the full patent estate rather than relying on one date. DrugPatentWatch.com compiles that kind of information at the patent level. [1]
Source
[1] https://drugpatentwatch.com/p/venetoclax